These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 27373922)

  • 1. Optical Resolution by the Replacing Crystallization of DL-Threonine with L-Alanine as an Optically Active Cosolute.
    Shiraiwa T; Kubo M; Fukuda K; Kurokawa H
    Biosci Biotechnol Biochem; 1999; 63(12):2212-5. PubMed ID: 27373922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of optically active allothreonine via optical resolution by replacing crystallization.
    Shiraiwa T; Fukuda K; Kubo M
    Chem Pharm Bull (Tokyo); 2002 Feb; 50(2):287-91. PubMed ID: 11848226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical Resolution by Preferential Crystallization of (RS)-2-Amino-3-(2-carboxyethylthio)propanoic Acid.
    Shiraiwa T; Kubo M; Watanabe M; Nakatani H; Ohkubo M; Kurokawa H
    Biosci Biotechnol Biochem; 1998; 62(4):818-20. PubMed ID: 27392566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of optically active (2RS,3SR)-2-amino-3-hydroxy-3-phenylpropanoic acid (threo-beta-phenylserine) via optical resolutions by replacing and preferential crystallization.
    Shiraiwa T; Kawashima Y; Ikaritani A; Suganuma Y; Saijoh R
    Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1170-4. PubMed ID: 16880663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of optically active 2-aminobutanoic acid via optical resolution by replacing crystallization.
    Yajima T; Aizawa Y; Nishida M; Sakaguchi Y; Shiraiwa T
    Biosci Biotechnol Biochem; 2007 May; 71(5):1338-41. PubMed ID: 17485843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of Optically Active 1,4-Thiazane-3-carboxylic Acid via Optical Resolution by Preferential Crystallization of (RS)-2-Amino-3-[(2-chloroethyl)sulfanyl]propanoic Acid Hydrochloride.
    Shiraiwa T; Tadokoro K; Tanaka H; Nanba K; Yokono N; Shibazaki K; Kubo M; Kurokawa H
    Biosci Biotechnol Biochem; 1998; 62(12):2382-7. PubMed ID: 27392398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of optically active allothreonine by separating from a diastereoisomeric mixture with threonine.
    Yajima T; Ichimura S; Horii S; Shiraiwa T
    Biosci Biotechnol Biochem; 2010; 74(10):2106-9. PubMed ID: 20944423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Online monitoring of preferential crystallization of enantiomers.
    Alvarez Rodrigo A; Lorenz H; Seidel-Morgenstern A
    Chirality; 2004 Oct; 16(8):499-508. PubMed ID: 15290684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous resolution of binary copper(II) complexes with racemic dipeptides: crystal structures of glycyl-L-alpha-amino-n-butyrato copper(II) monohydrate, glycyl-D-valinato copper(II) hemihydrate, and glycyl-L-valinato copper(II) hemihydrate.
    Inomata Y; Yamaguchi T; Tomita A; Yamada D; Howell FS
    J Inorg Biochem; 2005 Aug; 99(8):1611-8. PubMed ID: 15963569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical resolution by preferential crystallization of (RS)-2-benzoylamino-2-benzyl-3-hydroxypropanoic acid and its use in synthesizing optically active 2-amino-2-methyl-3-phenylpropanoic acid.
    Shiraiwa T; Suzuki M; Sakai Y; Nagasawa H; Takatani K; Noshi D; Yamanashi K
    Chem Pharm Bull (Tokyo); 2002 Oct; 50(10):1362-6. PubMed ID: 12372863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enantioseparation by crystallization using magnetic substrates.
    Tassinari F; Steidel J; Paltiel S; Fontanesi C; Lahav M; Paltiel Y; Naaman R
    Chem Sci; 2019 May; 10(20):5246-5250. PubMed ID: 31191879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-Reporting Inhibitors: A Single Crystallization Process To Obtain Two Optically Pure Enantiomers.
    Ye X; Cui J; Li B; Li N; Zhang J; Wan X
    Angew Chem Int Ed Engl; 2018 Jul; 57(27):8120-8124. PubMed ID: 29790235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexpected differences between D- and L- tyrosine lead to chiral enhancement in racemic mixtures.
    Shinitzky M; Nudelman F; Barda Y; Haimovitz R; Chen E; Deamer DW
    Orig Life Evol Biosph; 2002 Aug; 32(4):285-97; discussion 283. PubMed ID: 12458733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical resolution of amino acid derivatives by micellar electrokinetic chromatography with N-dodecanoyl-L-serine.
    Otsuka K; Karuhaka K; Higashimori M; Terabe S
    J Chromatogr A; 1994 Sep; 680(1):317-20. PubMed ID: 7952008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of d- and l-enantiomers of threonine and allo-threonine in mammals using two-step high-performance liquid chromatography.
    Zhao H; Hamase K; Morikawa A; Qiu Z; Zaitsu K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(2):245-50. PubMed ID: 15380721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of methanol and urea on optical resolution of phenylthiohydantoin-DL-amino acids by micellar electrokinetic chromatography with sodium N-dodecanoyl-L-valinate.
    Otsuka K; Terabe S
    Electrophoresis; 1990 Nov; 11(11):982-4. PubMed ID: 2079049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of optically active proline. Optical resolution of N-acyl-DL-proline by preferential crystallization procedure.
    Hongo C; Shibazaki M; Yamada S; Chibata I
    J Agric Food Chem; 1976; 24(5):903-6. PubMed ID: 965604
    [No Abstract]   [Full Text] [Related]  

  • 18. Resolution of DL-amino acids by preferential crystallization procedure, I. Preparation of optically active alanines.
    Chibata I; Yamada S; Yamamoto M; Wada M
    Experientia; 1968 Jun; 24(6):638-9. PubMed ID: 5697764
    [No Abstract]   [Full Text] [Related]  

  • 19. Preparation of optically pure δ-lactones using diastereomeric resolution with amino acid as resolving agent.
    Shimotori Y; Hoshi M; Seki S; Osanai T; Okabe H; Ikeda Y; Miyakoshi T
    J Oleo Sci; 2015; 64(1):75-90. PubMed ID: 25742924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrier design: conformational studies of amino acid (X) and oligopeptide (X-DL-Alam) substituted poly (L-lysine).
    Mezö G; Kajtár J; Hudecz F; Szekerke M
    Biopolymers; 1993 Jun; 33(6):873-85. PubMed ID: 8318662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.